These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1653465)

  • 1. 5-HT3 receptor blockers.
    Smith RA
    Surgery; 1991 Sep; 110(3):575. PubMed ID: 1653465
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man.
    Sommers DK; Snyman JR; van Wyk M
    Eur J Clin Pharmacol; 1993; 44(4):337-9. PubMed ID: 8390368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxytryptamine (5-HT)-induced depolarization in isolated abdominal vagus nerves in the rat: involvement of 5-HT3 and 5-HT4 receptors.
    Nemoto M; Endo T; Minami M; Yoshioka M; Ito H; Saito H
    Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):217-30. PubMed ID: 11758651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
    Endo T; Sugawara J; Nemoto M; Minami M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):227-39. PubMed ID: 10342910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.
    Miyata K; Kamato T; Nishida A; Ito H; Katsuyama Y; Iwai A; Yuki H; Yamano M; Tsutsumi R; Ohta M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):15-21. PubMed ID: 1656016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum.
    Tuladhar BR; Kaisar M; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1174-8. PubMed ID: 9401783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology].
    d'Allens H; Aubert B; Bons J; Pappo M
    Bull Cancer; 1991; 78(12):1139-46. PubMed ID: 1838490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.
    Upward JW; Arnold BD; Link C; Pierce DM; Allen A; Tasker TC
    Eur J Cancer; 1990; 26 Suppl 1():S12-5. PubMed ID: 2169778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B; Naylor RJ
    Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
    Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
    J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets.
    Endo T; Ogawa T; Hamaue N; Akita K; Hirafuji M; Minami M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation.
    Martin C; Roman V; Agay D; Fatôme M
    Radiat Res; 1998 Jun; 149(6):631-6. PubMed ID: 9611102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis.
    Blower PR
    Eur J Cancer; 1990; 26 Suppl 1():S8-11. PubMed ID: 2169786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
    Rojas C; Stathis M; Thomas AG; Massuda EB; Alt J; Zhang J; Rubenstein E; Sebastiani S; Cantoreggi S; Snyder SH; Slusher B
    Anesth Analg; 2008 Aug; 107(2):469-78. PubMed ID: 18633025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
    Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central 5-HT1A receptors and vagal tone to the airways.
    Ramage AG
    Trends Pharmacol Sci; 2000 Jun; 21(6):201-3. PubMed ID: 10838602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.